Dongsung Chemical
Key metrics
Earnings
| Revenue, Q3 2026 | ₩327.8bn |
|---|---|
| Revenue QoQ | -7.0% |
| Revenue YoY | +4.0% |
| Operating income, Q3 2026 | ₩29.7bn |
| Operating income QoQ | -35.6% |
| Operating income YoY | -13.3% |
Share buybacks
| Buyback decided, last 3 months | ₩0 |
|---|---|
| Buyback decided, last 3 months, % of shares | 0.0% |
| Shares acquired, last 3 months | ₩0 |
| Shares acquired, last 3 months, % of shares | 0.0% |
| Treasury shares cancelled, last 3 months | ₩4.2bn |
| Treasury shares cancelled (number), last 3 months | 899,657 shares |
| Treasury shares cancelled, last 3 months, % of shares | 1.8% |
| Buyback decided, last 12 months | ₩0 |
| Buyback decided, last 12 months, % of shares | 0.0% |
| Shares acquired, last 12 months | ₩0 |
| Shares acquired, last 12 months, % of shares | 0.0% |
| Treasury shares cancelled, last 12 months | ₩4.2bn |
| Treasury shares cancelled (number), last 12 months | 899,657 shares |
| Treasury shares cancelled, last 12 months, % of shares | 1.8% |
Potential dilution
| CB/BW/EB issued, last 12 months | ₩0 |
|---|---|
| Rights offering new shares, last 12 months | 0 shares |
| Potential new shares, last 12 months | 0 shares |
| Potential new shares, % of shares | 0.0% |
| Conversion price adjustments, last 12 months | 0 |
Supply contracts
| Supply contracts, last 12 months | ₩0 |
|---|---|
| Supply contracts vs prior-year revenue | 0.0% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Disclosure activity
| DART filings, last 3 months | 6 |
|---|---|
| DART filings, previous 3 months | 7 |
Insider transactions
| Open-market buys, last 12 months (shares) | 11,236 shares |
|---|---|
| Open-market buys, last 12 months (amount) | ₩43m |
| Open-market sells, last 12 months (shares) | 0 shares |
| Open-market sells, last 12 months (amount) | ₩0 |
| Net open-market buying, last 12 months (shares) | 11,236 shares |
| Insiders who bought, last 12 months | 2 |
Insider transactions (last 12 months)
Open-market buys: 11,236 shares (₩43m). Open-market sells: 0 shares (₩0). Net open-market buying: +11,236 shares. Insiders who bought: 2.
| Trade date | Insider (role) | Type | Shares | Price | Amount | |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | Baek Jin-u (Registered director, Controlling shareholder) | Open-market buy | +2,699 shares | ₩3,685 | ₩10m | |
| Jul 7, 2026 | Baek Jin-u (Registered director, Controlling shareholder) | Open-market buy | +2,788 shares | ₩3,569 | ₩10m | |
| Jun 29, 2026 | Lee Man-u (Registered director) | Open-market buy | +1,000 shares | ₩3,500 | ₩4m | |
| Apr 7, 2026 | Baek Jin-u (Registered director, Controlling shareholder) | Open-market buy | +2,350 shares | ₩4,235 | ₩10m | |
| Mar 26, 2026 | Lee Yeon-ju (Non-registered officer) | Other | +7 shares | — | — | |
| Mar 26, 2026 | Jung Deok-u (Non-registered officer) | Other | +10 shares | — | — | |
| Mar 26, 2026 | Shin Hyeong-cheol (Non-registered officer) | Other | +73 shares | — | — | |
| Mar 26, 2026 | Ha Jae-ryang (Non-registered officer) | Other | +33 shares | — | — | |
| Mar 26, 2026 | Cho Seong-won (Non-registered officer) | Other | +50 shares | — | — | |
| Mar 26, 2026 | Shin Seong-hui (Non-registered officer) | Other | +35 shares | — | — | |
| Mar 26, 2026 | Lee Man-u (Registered director) | Other | +90 shares | — | — | |
| Mar 26, 2026 | Baek Jin-u (Registered director, Controlling shareholder) | Other | +880 shares | — | — | |
| Mar 26, 2026 | DSTI CO., LTD (10%+ shareholder) | Other | +208,514 shares | — | — | |
| Jan 7, 2026 | Baek Jin-u (Registered director, Controlling shareholder) | Open-market buy | +2,399 shares | ₩4,150 | ₩10m | |
| Jan 1, 2026 | Lee Yeon-ju (Non-registered officer) | Other (New appointment) | +770 shares | — | — |
Annual financials
| Year | Revenue | Operating income |
|---|---|---|
| 2025 | ₩1.2tn | ₩112.0bn |
| 2024 | ₩1.1tn | ₩91.0bn |
| 2023 | ₩1.1tn | ₩81.6bn |
Filing timeline
-
DONGSUNG CHEMICAL to cancel 899,657 treasury shares on Nov 30, 2026
DONGSUNG CHEMICAL Co., Ltd. filed on Nov 13, 2026 to cancel 899,657 treasury shares, valued at ₩4.2bn. The planned cancellation date is Nov 30, 2026. The shares represent 1.8% of the 50,669,591 shares outstanding.